{"result": "(\"entity\"<|>SOLUCIONES NITROGENADAS<|>ORGANIZATION<|>Soluciones nitrogenadas refers to nitrogen solutions used in parenteral nutrition, providing essential amino acids and nitrogen for patients.)\n##\n(\"entity\"<|>SOLUCIONES LIPIDICAS<|>ORGANIZATION<|>Soluciones lipídicas are lipid solutions used in parenteral nutrition to provide essential fatty acids and calories.)\n##\n(\"entity\"<|>NP PERIFERICA HIPOCALORICA<|>EVENT<|>NP periférica hipocalórica refers to a specific type of hypocaloric peripheral parenteral nutrition solution used in clinical settings.)\n##\n(\"entity\"<|>TABLA 3<|>EVENT<|>Tabla 3 presents combinations of nitrogen and glucose solutions for hypocaloric peripheral parenteral nutrition.)\n##\n(\"entity\"<|>TABLA 4<|>EVENT<|>Tabla 4 outlines commercial preparations of parenteral nutrition, including ternary mixtures.)\n##\n(\"entity\"<|>TABLA 4A<|>EVENT<|>Tabla 4A details the specific products manufactured by Braun for parenteral nutrition.)\n##\n(\"relationship\"<|>SOLUCIONES NITROGENADAS<|>NUTRITION PARENTERAL<|>Soluciones nitrogenadas are used in the context of nutrition parenteral to provide essential nutrients<|>7)\n##\n(\"relationship\"<|>SOLUCIONES LIPIDICAS<|>NUTRITION PARENTERAL<|>Soluciones lipídicas are used in the context of nutrition parenteral to provide essential fatty acids<|>7)\n##\n(\"relationship\"<|>NP PERIFERICA HIPOCALORICA<|>NUTRITION PARENTERAL<|>NP periférica hipocalórica is a specific application of nutrition parenteral<|>6)\n##\n(\"relationship\"<|>TABLA 3<|>NUTRITION PARENTERAL<|>Tabla 3 provides information on solutions used for nutrition parenteral<|>5)\n##\n(\"relationship\"<|>TABLA 4<|>NUTRITION PARENTERAL<|>Tabla 4 outlines preparations relevant to nutrition parenteral<|>5)\n##\n(\"relationship\"<|>TABLA 4A<|>NUTRITION PARENTERAL<|>Tabla 4A details specific products related to nutrition parenteral<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 25-2,82 g DHA 1,44-3,09 g |\n| Presentaciones (ml) | 250, 333 | 100, 250, 500 | 100, 250, 350, 500, 1000 | 100, 250, 500 | 100, 250, 500 | 100, 250, 500, 1000 | 100, 250, 500 | 100 |\n| LCT g/l | 300 | 200 | 200 | 50 | 100 | 100 | 60 (soja) 50 (oliva) | |\n| MCT g/l | - | - | - | 50 | 100 | 80 | 60 | |\n| Omega-3 g/l | - | - | - | - | - | 20 | 30 | |\n| Lecitina g/l | 12 | 12 | 12 | 8 | 12 | 12 | 12 | |\n| Grasa g/l | 300 | 200 | 200 | 100 | 200 | 200 | 200 | 10 |\n| Fosfatos mmol/l | 15 | 15 | 15 | 15 | 15 | 15 | | |\n| Kcal/l | 3000 | 2000 | 2000 | 1022 | 1908 | 1910 | 1000 | 1120 |\n| Ph | 8 | | 6-8 | 8 ± 0,5 | 8 ± 0,5 | 8 ± 0,5 | 8 | 7,5-8,7 |\n| Osmolaridad | 310 | 270 | 310 | 345 | 380 | 410 | 380 | 273 |\n---\n988  Anexo 3. Soluciones nitrogenadas y lipídicas para nutrición parenteral\n\nTabla 3. Combinaciones comerciales de soluciones nitrogenadas y glucosadas para nutrición parenteral periférica hipocalórica empleadas habitualmente en nuestro medio.\n\n| | NP periférica hipocalórica |\n|---|---|---|\n| | Isoplasmal G® | Aminoven 3,5%® |\n| Volumen (ml) | 1000 | 1000 |\n| Nitrógeno g/l | 4,7 | 5,75 |\n| Aminoácidos g/l | 29,2 | 35 |\n| Glucosa g/l | 50 | 50 |\n| Na mEq/l | 28,5 | 50 |\n| K mEq/l | 20 | 30 |\n| Ca mEq/l | - | 4 |\n| Mg mEq/l | 3 | 6 |\n| Zn mEq/l | 0,16 | 0,08 |\n| Cl mEq/l | 28,8 | 46,7 |\n| Fósforo mmol/l | 5 | 15 |\n| Acetato mEq/l | 23 | - |\n| Kcal/l | 320 | 340 |\n| pH | 6,5 | 4,5-5,5 |\n| mOsm/l | 649 | 768,5 |\n---\nAnexo 3. Soluciones nitrogenadas y lipídicas para nutrición parenteral 989\n\nTabla 4. Preparados comerciales de nutrición parenteral (mezclas ternarias).\nTabla 4A. Fabricante Braun.\n\n| NuTRIflex Lipid | Peri | Plus | Special |\n|-----------------|------|------|---------|\n| Volumen (ml) | 1250 | 1875 | 2500 | 1250 | 1875* | 2500 | 1250* | 1875* |\n| AA (g) | 40 | 60 | 80 | 48 | 72 | 96 | 72 | 108 |\n| Nitrógeno (g) | 5,7 | 8,6 | 11,4 | 6,8 | 10,2 | 13,6 | 10 | 15 |\n| Glucosa (g) | 80 | 120 | 160 | 150 | 225 | 300 | 180 | 270 |\n| Lípidos (g) | 50 | 75 | 100 | 50 | 75 | 100 | 50 | 75 |\n| Calorías totales (kcal) | 955 | 1435 | 1910 | 1265 | 1900 | 2530 | 1475 | 2215 |\n| Kcal NP/g N2 | 140 | 140 | 140 | 158 | 158 | 158 | 120 | 120 |\n| Osmolaridad (mOsm/l) | 840 | 840 | 840 | 1215 | 1215 | 1215 | 1545 | 1545 |\n\nElectrolitos (mmol)\n| | | | | | | | | |\n|-------------|------|------|------|------|-------|------|-------|-------|\n| Sodio | 50 | 75 | 100 | 50 | 75 | 100 | 67 | 100,5 |\n| Potasio | 30 | 45 | 60 | 35 | 52,5 | 70 | 47 | 70,5 |\n| Calcio | 3 | 4,5 | 6 | 4 |\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ISOPLASMAL G<|>ORGANIZATION<|>Isoplasmal G is a commercial nitrogen solution used for hypocaloric peripheral parenteral nutrition.)\n##\n(\"entity\"<|>AMINOVEN 3,5%<|>ORGANIZATION<|>Aminoven 3,5% is a commercial nitrogen solution used for hypocaloric peripheral parenteral nutrition.)\n##\n(\"entity\"<|>BRAUN<|>ORGANIZATION<|>Braun is a manufacturer of commercial parenteral nutrition products, including NuTRIflex Lipid and other solutions.)\n##\n(\"entity\"<|>NUTRITION PARENTERAL<|>EVENT<|>Nutrition parenteral refers to the intravenous administration of nutrients, bypassing the digestive system, often used in clinical settings.)\n##\n(\"entity\"<|>NUTrIFLEX LIPID<|>ORGANIZATION<|>NuTRIflex Lipid is a product line by Braun that provides lipid-based nutrition solutions for patients requiring parenteral nutrition.)\n##\n(\"relationship\"<|>ISOPLASMAL G<|>AMINOVEN 3,5%<|>Both Isoplasmal G and Aminoven 3,5% are commercial solutions used for hypocaloric peripheral parenteral nutrition<|>7)\n##\n(\"relationship\"<|>BRAUN<|>NUTrIFLEX LIPID<|>Braun manufactures the NuTRIflex Lipid product line for parenteral nutrition<|>8)\n##\n(\"relationship\"<|>ISOPLASMAL G<|>NUTRITION PARENTERAL<|>Isoplasmal G is a solution used in the context of nutrition parenteral<|>6)\n##\n(\"relationship\"<|>AMINOVEN 3,5%<|>NUTRITION PARENTERAL<|>Aminoven 3,5% is a solution used in the context of nutrition parenteral<|>6)\n##\n(\"relationship\"<|>NUTrIFLEX LIPID<|>NUTRITION PARENTERAL<|>NuTRIflex Lipid is a product used for providing nutrition parenteral<|>6)\n<|COMPLETE|>"}]}